RNK05047
RNK05047 is a targeted protein degrader from Ranok Therapeutics (Hangzhou) Co., Ltd., in registered phase 2 trials for metastatic cancer.
Overview
RNK05047 is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Ranok Therapeutics (Hangzhou) Co., Ltd., in metastatic cancer. A targeted protein degrader, as described in the registry record: it tags a cancer-driving protein for destruction by the cell's own disposal system. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A targeted protein degrader, as described in the registry record: it tags a cancer-driving protein for destruction by the cell's own disposal system.
1.RNK05047 binds its target with one end and an E3 ubiquitin ligase with the other.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"RNK05047" OR ABSTRACT:"RNK05047") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about RNK05047, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentEVM14
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentHST-1011
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentIPG1094
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentSelicrelumab
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentCamonsertib
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentEvexomostat
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentMerestinib
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.
- TreatmentOBI-902
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.